Navigation Links
ADVENTRX Reports Second Quarter 2011 Financial Results
Date:8/8/2011

SAN DIEGO, Aug. 8, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the periods ended June 30, 2011.

"As we head into the second half of the year, we are taking steps to prepare for our launch of Exelbine™ into the U.S. market, should it be approved on or around FDA's PDUFA goal date of September 1, 2011," said Brian M. Culley, Chief Executive Officer of ADVENTRX.  "Having a commercial infrastructure will expand our strategic options and increase stockholder value."

"In parallel, we are working to finalize the protocol for a phase 3 pediatric study of ANX-188, our first-in-class treatment for sickle cell crisis, for which FDA has granted orphan drug designation. We plan to initiate this study in 2012.  There are no FDA-approved drugs designed to treat patients in crisis, making this an area of significant unmet need," Mr. Culley continued.  

"We also are excited about ANX-514, our detergent-free reformulation of the blockbuster drug Taxotere®, which recently went off-patent.  We plan to meet with FDA in the next quarter to discuss a single, additional study in which we compare the safety profiles of Taxotere with corticosteroid premedication and ANX-514 without corticosteroid premedication.  We believe this single study will provide sufficient clinical data to support a new drug application, should the study demonstrate comparable safety profiles between ANX-514 and Taxotere, and a competitive advantage over Taxotere and other detergent-containing formulations of docetaxel," Mr. Culley concluded.  

Second Quarter 2011 Operating ResultsADVENTRX's net loss applicable to common stock for the second quarter of 2011 was $4.4 million, or $0.17 per share, compared to a net loss applicable to common stock of $5.0 million, or $0.39 per share, for the same period in
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
2. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
3. ADVENTRX Reports First Quarter 2011 Financial Results
4. ADVENTRX Completes Acquisition of SynthRx
5. ADVENTRX Pharmaceuticals Provides Update on ANX-514
6. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
7. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
8. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
9. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
10. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
11. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014  Lockton Dunning Benefits, the ... announced the addition of Vice President Kim ... Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... experience to the position.  Most recently, she worked ... Diplomat Specialty Pharmacy, where she has held various ...
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Endo Pharmaceuticals ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, ... they have submitted a New Drug Application (NDA) for ... Drug Administration (FDA).  Buprenorphine HCl Buccal Film is under ... require daily, around-the-clock, long-term opioid treatment and for which ...
(Date:12/22/2014)... Apnea Sciences ( www.apneasciences.com ) announced it ... Aliso Viejo , California.  Jimmy Fallon , ... and worldwide expansion, a new facility with expanded infrastructure ... snore cure have exceeded our expectations and thus required ... in 23 countries and will be increasing to 39 ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... , ROCKVILLE, Md. , Feb. ... new data from a clinical study that began in May of ... Novavax,s trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched ... A/ Brisbane /59/2007, H3N2 A/ Brisbane /10/2007, and B/ Florida /04/2006 ...
... , SAN DIEGO , Feb. 8 ... of patient safety solutions that help to eliminate hospital-based medical ... in Series B-1 financing. The financing was led by ... global private equity firm, TPG Capital. Co-leads for this financing ...
Cached Medicine Technology:NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 2NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 3NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults 4PatientSafe Solutions, Inc. Closes $30 Million Financing 2PatientSafe Solutions, Inc. Closes $30 Million Financing 3
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... Analysis to 2023” focuses on the current treatment ... in the colorectal cancer market. Stivarga is a ... colon or rectal cancer. Boehringer Ingelheim is developing ... the treatment of refractory CRC in the US, ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
(Date:12/25/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Among early ... treatment, less than half of one percent will eventually ... new analysis reveals. The finding comes from a ... between 1998 and 2007, and it suggests that the ... double what experts had previously thought. "The frequency ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios have ... business presentation tool made specifically for Final Cut ... tool, users can now display their stats and facts ... Studios. “ProFire 5k gives users a multiple options to ... a presentation” , Pixel Film Studios takes the heat ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... ... Than $235 Million in Gross Settlements , ... Wellesley, MA (PRWEB) January 26, 2010 -- Sokolove Law LLC, the leader ... and their families living in Illinois on its Mesothelioma Resource Center website, MesoRC.com. The MesoRC.com ...
... ... Care Delivery System , ... Washington, DC (Vocus) January 26, 2010 -- Community oncologists nationwide, under the support ... President Obama and lawmakers to reverse drastic cuts in reimbursement for cancer care implemented ...
... , REDWOOD CITY, Calif. , ... has selected DigitalPersona, Inc., a leader in fingerprint identity and authentication ... Information System (CJIS) mandates. Located in Central Florida , The ... serve more than 28,000 residents. The City chose DigitalPersona ® ...
... ... matching gift for relief efforts in Haiti. , ... Berkeley Heights, NJ (Vocus) January 26, 2010 -- Summit Medical Group ... by offering its employees the opportunity to donate via a one-time payroll deduction from their ...
... ... Group (HDG), one of the nation’s leading senior-focused health care management ... Nell Zellner as senior vice president of consulting, effective January 1.,Zellner ... practice, which provides senior care solutions for hospitals and health systems, ...
... ... only four companies to receive accreditation for the new ESTA code of practice for gas data ... Horley, UK ... companies, to date, to receive accreditation for the new ESTA code of practice for gas data ...
Cached Medicine News:Health News:Sokolove Law's MesoRC Site Serves Illinois Mesothelioma Patients and their Families 2Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 2Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 3Health News:City of Winter Park Looks to DigitalPersona Software for Stronger Security and CJIS Compliance 2Health News:City of Winter Park Looks to DigitalPersona Software for Stronger Security and CJIS Compliance 3Health News:City of Winter Park Looks to DigitalPersona Software for Stronger Security and CJIS Compliance 4Health News:Summit Medical Group Raises 30K for Haiti Earthquake Relief 2Health News:Health Dimensions Group Appoints Mary Nell Zellner as Senior Vice President of Consulting 2Health News:Stark Receives Accreditation for ESTA's New Code of Practice 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: